RNADIAGON - Excellence in research and development of non-coding RNA DIAGnostics in ONcology
RNADIAGON is an academic-industrial consortium focused on research and development it the field of non-coding RNA diagnostics in oncology.
This consortium enables development of personal skills and knowledge of early-stage and experienced researchers from 5 European academic centers through their (i) long-term stays at the US research center of excellence (MD Anderson Cancer Center, University of Texas, USA) and (ii) traineeships at the education center and manufacturing facilities of industrial partner (BioVendor, Inc.) developing certified (CE-IVD) diagnostics, who will work on the development of a new non-coding RNA diagnostic kit in colorectal cancer adopted here as a model project.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska- Curie grant agreement no. 824036 – RNADIAGON.
This website reflects only the author's view and the Research Executive Agency (REA) is not responsible for any use that may be made of the information it contains.